Raziel, Fosun Start Ph3 China Trial For Submental Fat Reduction
03 Mar 2025 //
PR NEWSWIRE
Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012Â
17 Sep 2020 //
PRNEWSWIRE
Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012
16 Sep 2020 //
PRNEWSWIRE
Fat Melting Pharmaceutical Company Raziel Raises $22 Million in Series C
18 Dec 2019 //
PR NEWSWIRE